News
UCSF School of Pharmacy leads in NIH funding for the 40th straight year
School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school—for the 40th consecutive year.
2019 Koda-Kimble Seed Award supports School of Pharmacy’s boldest ideas
The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.
School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year
Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.
QBI pioneers a collaborative and inclusive approach to scientific discovery
UCSF’s Quantitative Biosciences Institute (QBI), founded two years ago, is making waves with its unique approach to scientific collaboration, catalyzing discoveries from cancer to psychiatry while supporting female scientists and engaging with the public.
Sali elected to National Academy of Sciences
Andrej Sali, PhD, has been elected as a member of the 2018 class of the National Academy of Sciences (NAS).
Behind enemy lines
New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.
UCSF School of Pharmacy leads in NIH funding for 38th year
A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”
Taking a bite out of the proteome with PhaNGS
If DNA is the blueprint for every cell in the body, then proteins are the cell’s construction workers, forklifts, and building materials.
Update from the Dean – March 2018
A new PharmD curriculum; Implementing new practice opportunities for pharmacists; PharmD students shine in state and national clinical pharmacy competitions; A pioneer in pharmacogenomics; The NIH streak lives on; Improving adverse event reporting and medication therapy protocols; Big-data to cut drug discovery time; Computational approaches target dopamine receptors; Researchers expose industry manipulation of science by sugar industry; Women in science; more.
Babbitt named fellow of the International Society for Computational Biology
Babbitt's election as a 2018 ISCB fellow highlights her contributions to the fields of computational biology and bioinformatics.
Unmasking a cellular hallmark of cancer
Scientists identify a signature of cancers caused by mutant RAS that may lead to precise therapies.
Microscopy illuminates life
Even with the best of microscopes, it's still a challenge to visualize the "inner life" of the cell.